Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 10;60:24-31.
doi: 10.1016/j.enzmictec.2014.04.003. Epub 2014 Apr 13.

Chemotherapy Pro-Drug Activation by Biocatalytic Virus-Like Nanoparticles Containing Cytochrome P450

Affiliations

Chemotherapy Pro-Drug Activation by Biocatalytic Virus-Like Nanoparticles Containing Cytochrome P450

Lorena Sánchez-Sánchez et al. Enzyme Microb Technol. .

Abstract

This work shows, for the first time, the encapsulation of a highly relevant protein in the biomedical field into virus-like particles (VLPs). A bacterial CYP variant was effectively encapsulated in VLPs constituted of coat protein from cowpea chlorotic mottle virus (CCMV). The catalytic VLPs are able to transform the chemotherapeutic pro-drug, tamoxifen, and the emerging pro-drug resveratrol. The chemical nature of the products was identified, confirming similar active products than those obtained with human CYP. The enzymatic VLPs remain stable after the catalytic reaction. The potential use of these biocatalytic nanoparticles as targeted CYP carriers for the activation of chemotherapy drugs is discussed.

Keywords: Bionanotechnology; CYP; Catalytic VLPs; Resveratrol; Tamoxifen.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback